ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Tennessee » Neurological Surgery

Top Neurological Surgery Prescribers in Tennessee

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
HOWARD KIRSHNER MD

Neurological Surgery

2,937

$241K

252
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 18%

8%
patients receiving schedule three controlled substances

Avg: 38%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

22%
prescriptions for brand name drugs

Avg: 8%

$82
Average prescription price

Avg: $136

PETER HEDERA MD

Neurological Surgery

2,699

$921K

165
111 are 65+

0%
patients receiving schedule two controlled substances

Avg: 18%

0%
patients receiving schedule three controlled substances

Avg: 38%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

18%
prescriptions for brand name drugs

Avg: 8%

$341
Average prescription price

Avg: $136

DEKA EFOBI MD

Neurological Surgery

2,332

$204K

283
181 are 65+

8%
patients receiving schedule two controlled substances

Avg: 18%

18%
patients receiving schedule three controlled substances

Avg: 38%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

26%
prescriptions for brand name drugs

Avg: 8%

$88
Average prescription price

Avg: $136

GRETCHEN CAMPBELL MD

Neurological Surgery

2,031

$599K

227
148 are 65+

9%
patients receiving schedule two controlled substances

Avg: 18%

11%
patients receiving schedule three controlled substances

Avg: 38%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

28%
prescriptions for brand name drugs

Avg: 8%

$295
Average prescription price

Avg: $136

SUBRAMANIAM SRIRAM MD

Neurological Surgery

1,902

$1.7M

122
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 18%

9%
patients receiving schedule three controlled substances

Avg: 38%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

34%
prescriptions for brand name drugs

Avg: 8%

$891
Average prescription price

Avg: $136

CHRISTINE DONG MD

Neurological Surgery

1,850

$111K

211
143 are 65+

0%
patients receiving schedule two controlled substances

Avg: 18%

5%
patients receiving schedule three controlled substances

Avg: 38%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

17%
prescriptions for brand name drugs

Avg: 8%

$60
Average prescription price

Avg: $136

VAUGHAN ALLEN M.D.

Neurological Surgery

1,560

$36.2K

378
263 are 65+

5%
patients receiving schedule two controlled substances

Avg: 18%

60%
patients receiving schedule three controlled substances

Avg: 38%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

8%
prescriptions for brand name drugs

Avg: 8%

$23
Average prescription price

Avg: $136

TIMOTHY SCHOETTLE M.D.

Neurological Surgery

1,200

$46.3K

207
130 are 65+

11%
patients receiving schedule two controlled substances

Avg: 18%

40%
patients receiving schedule three controlled substances

Avg: 38%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

11%
prescriptions for brand name drugs

Avg: 8%

$39
Average prescription price

Avg: $136

EVERETTE HOWELL M.D.

Neurological Surgery

1,079

$37.9K

205
161 are 65+

15%
patients receiving schedule two controlled substances

Avg: 18%

41%
patients receiving schedule three controlled substances

Avg: 38%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

8%
prescriptions for brand name drugs

Avg: 8%

$35
Average prescription price

Avg: $136

REX ARENDALL M.D.

Neurological Surgery

953

$28.7K

197
122 are 65+

33%
patients receiving schedule two controlled substances

Avg: 18%

41%
patients receiving schedule three controlled substances

Avg: 38%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

6%
prescriptions for brand name drugs

Avg: 8%

$30
Average prescription price

Avg: $136

SCOTT STANDARD M.D.

Neurological Surgery

843

$32.8K

208
153 are 65+

16%
patients receiving schedule two controlled substances

Avg: 18%

45%
patients receiving schedule three controlled substances

Avg: 38%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

11%
prescriptions for brand name drugs

Avg: 8%

$39
Average prescription price

Avg: $136

PRADUMNA SINGH M.D.

Neurological Surgery

746

$186K

65
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 18%

0%
patients receiving schedule three controlled substances

Avg: 38%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

21%
prescriptions for brand name drugs

Avg: 8%

$249
Average prescription price

Avg: $136

PAUL MOOTS MD

Neurological Surgery

732

$139K

71
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 18%

0%
patients receiving schedule three controlled substances

Avg: 38%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

14%
prescriptions for brand name drugs

Avg: 8%

$189
Average prescription price

Avg: $136

JOSEPH JESTUS M.D.

Neurological Surgery

604

$12K

232
173 are 65+

20%
patients receiving schedule two controlled substances

Avg: 18%

48%
patients receiving schedule three controlled substances

Avg: 38%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

4%
prescriptions for brand name drugs

Avg: 8%

$20
Average prescription price

Avg: $136

LAWRENCE HARTMAN M.D.

Neurological Surgery

600

$17.4K

166
81 are 65+

26%
patients receiving schedule two controlled substances

Avg: 18%

27%
patients receiving schedule three controlled substances

Avg: 38%

17%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

4%
prescriptions for brand name drugs

Avg: 8%

$29
Average prescription price

Avg: $136

GREGORY LANFORD M.D.

Neurological Surgery

598

$9,634

143
101 are 65+

8%
patients receiving schedule two controlled substances

Avg: 18%

57%
patients receiving schedule three controlled substances

Avg: 38%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

5%
prescriptions for brand name drugs

Avg: 8%

$16
Average prescription price

Avg: $136

SEYED EMADIAN MD PH D

Neurological Surgery

595

$4,623

124
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 18%

84%
patients receiving schedule three controlled substances

Avg: 38%

20%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

0%
prescriptions for brand name drugs

Avg: 8%

$8
Average prescription price

Avg: $136

JULIUS FERNANDEZ MD

Neurological Surgery

586

$20.2K

139
92 are 65+

18%
patients receiving schedule two controlled substances

Avg: 18%

45%
patients receiving schedule three controlled substances

Avg: 38%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

11%
prescriptions for brand name drugs

Avg: 8%

$34
Average prescription price

Avg: $136

AMANDA PELTIER MD

Neurological Surgery

575

$394K

82
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 18%

0%
patients receiving schedule three controlled substances

Avg: 38%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

30%
prescriptions for brand name drugs

Avg: 8%

$685
Average prescription price

Avg: $136

PETER BOEHM M.D.

Neurological Surgery

526

$20.4K

119
68 are 65+

11%
patients receiving schedule two controlled substances

Avg: 18%

27%
patients receiving schedule three controlled substances

Avg: 38%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

10%
prescriptions for brand name drugs

Avg: 8%

$39
Average prescription price

Avg: $136

RICHARD BOYER MD

Neurological Surgery

520

$38.8K

144
59 are 65+

38%
patients receiving schedule two controlled substances

Avg: 18%

40%
patients receiving schedule three controlled substances

Avg: 38%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

8%
prescriptions for brand name drugs

Avg: 8%

$75
Average prescription price

Avg: $136

WILLIAM SCHOOLEY M.D.

Neurological Surgery

514

$22.5K

102
25 are 65+

42%
patients receiving schedule two controlled substances

Avg: 18%

42%
patients receiving schedule three controlled substances

Avg: 38%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

7%
prescriptions for brand name drugs

Avg: 8%

$44
Average prescription price

Avg: $136

PAUL MCCOMBS MD

Neurological Surgery

507

$10.4K

137
92 are 65+

12%
patients receiving schedule two controlled substances

Avg: 18%

55%
patients receiving schedule three controlled substances

Avg: 38%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

5%
prescriptions for brand name drugs

Avg: 8%

$20
Average prescription price

Avg: $136

TODD ABEL MD

Neurological Surgery

495

$12.4K

128
57 are 65+

32%
patients receiving schedule two controlled substances

Avg: 18%

53%
patients receiving schedule three controlled substances

Avg: 38%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

3%
prescriptions for brand name drugs

Avg: 8%

$25
Average prescription price

Avg: $136

JAMES FEILD M.D.

Neurological Surgery

434

$11.5K

98
65 are 65+

32%
patients receiving schedule two controlled substances

Avg: 18%

50%
patients receiving schedule three controlled substances

Avg: 38%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

9%
prescriptions for brand name drugs

Avg: 8%

$27
Average prescription price

Avg: $136

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank